Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 11, 2000

View Archived Issues

Carvedilol surpasses metoprolol in long-term heart failure treatment

EPTTCO and Onyx establish agreement for anticancer agents

Etanercept is well tolerated and efficacious as psoriatic arthritis and psoriasis treatment

Secretin studies in autism reported at pediatric gastroenterology conference

Showa Yakuhin to market CollaGenex's Periostat in Japan

Vion receives NCI research contract to explore TAPET in tumor imaging

Biomira initiates phase IIb trial of BLP25 vaccine

Protein implicated in Ebola virus toxicity

Spherons potentially linked to Alzheimer's disease

Retinoid supplementation improves mouse model of childhood blindness

Mice bred to develop neurofibrillary tangles for dementia research

Access to Kaletra early access program expanded for HIV patients

Prous Science selected official internet and multimedia provider for XXII ESC Congress

Glutamate/serotonin interactions in prefrontal cortex explored

Maxim and Roche to develop combination therapy for hepatitis C and cancer

Theratechnologies to begin PDT trial in Canada

Elan and Pharmacia to collaborate on developing beta-secretase inhibitors

New compounds at Aventis show activity against Gram-positive bacteria

Factor Xa inhibitors under study at Aventis useful for thromboembolic diseases

Tachykinin antagonists discovered at Nippon Zoki

Novel isochroman compound useful for Alzheimer's disease

Janssen receives patent for new antihistaminic series

New compounds interacting with 5-HT6 receptors under development at Merck KGaA

New farnesyl protein transferase inhibitors useful for various tumors

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...